Eris Lifesciences Ltd Registered Shs 540596
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹1,275.90
- Day Range
- ₹1,249.00–1,280.00
- 52-Week Range
- ₹800.05–1,521.05
- Bid/Ask
- ₹0.00 / ₹0.00
- Market Cap
- ₹172.61 Bil
- Volume/Avg
- 8,600 / 20,723
Key Statistics
- Price/Earnings (Normalized)
- 46.73
- Price/Sales
- 7.74
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 4,665
- Website
- https://www.eris.co.in
Comparables
Valuation
|
Metric
|
540596
|
532815
|
543434
|
|---|---|---|---|
Price/Earnings (Normalized) | 46.73 | 52.55 | 34.56 |
Price/Book Value | 6.72 | 5.91 | 5.81 |
Price/Sales | 7.74 | 4.08 | 8.09 |
Price/Cash Flow | 34.24 | 36.20 | 36.48 |
Price/Earnings
540596
532815
543434
Financial Strength
|
Metric
|
540596
|
532815
|
543434
|
|---|---|---|---|
Quick Ratio | 0.26 | 0.86 | 2.47 |
Current Ratio | 0.91 | 1.61 | 5.17 |
Interest Coverage | 4.34 | 4.55 | 51.09 |
Quick Ratio
540596
532815
543434
Profitability
|
Metric
|
540596
|
532815
|
543434
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
540596
532815
543434
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Fwtpgmccrk | Hhtn | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Zfwbswzsh | Nztdrdm | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Pgqvzttgq | Pnzk | $48.4 Bil | |||
| Viatris Inc
VTRS
| Rcpjhwlt | Mvncw | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Bmmqhxmt | Vxrzy | $13.5 Bil | |||
| Catalent Inc
CTLT
| Yrlxlsy | Frrcg | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Crlhclctk | Bsrdr | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Mwylzgqr | Fwng | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Bgvglkhkr | Pbvb | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Bxzmrpvr | Jjfl | $2.3 Bil |
United States